SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (90)1/26/1999 11:45:00 AM
From: Epicenter  Read Replies (2) of 3158
 
Dear Peter:

I reviewed SUGN's portfolio recently. I think tyrosine kinase inhibitors are a difficult bunch of targets to get good drugs, in general. I am also not so sure how well the company is run (with famous scientists on the advisory board, sometimes this is a hindrance than a merit--as in the case of ARIAD). For what's its worth, SUGN is pretty low on my list to invest.

Epicenter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News